AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2021
Jul 8, 2021
35167_dirs_2021-07-08_7b1ddb91-cad2-4941-be39-fa5c4d0de5fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2021-06-17
Reporting Person: Litchman Manuel MD (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-17 | COMMON STOCK | A | 61000 | — | Acquired | 874035 | Direct |
Footnotes
F1: Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years.
F2: Includes restricted stock units, which vest over various time periods.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7